Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

ImPACT Applications introduces pediatric medical device for concussion management

ImPACT Applications has introduced new FDA-approved pediatric medical device for concussion management.

Impact Pediatric, which is designed for individuals from age 5 to 11, provides health care professionals with objective measures of neurocognitive functioning for evaluation and management of concussion in younger children.

ImPACT Pediatric is an iPad-based computerized test, which is individually administered, helping to engage children easily in a clinical setting.

The device can effectively measure neurocognitive function in the children, according to the company.

In addition, the company provides FDA-approved ImPACT computerized neurocognitive concussion assessment and management tool for concussion management in individuals aged between 12 and 59.

Computerized cognitive assessment aid for concussion is a new category for a device, which uses an individual's score(s) on a battery of cognitive tasks to provide an indication of the current level of cognitive function in response to concussion.

ImPACT Applications CEO Michael Wahlster said: "ImPACT Pediatric is a huge step forward for the industry and specifically for pediatric patients who are at-risk of concussion-related injuries.

"Unlike older age groups who are often baseline tested before injury, concussion management for young children is mostly reactive.

“ImPACT Pediatric allows for proactive baseline testing for well-child patients and insight into cognitive changes if an injury occurs.”

Around two million children are expected to suffer sports-related concussions each year, according to a study by researchers from the University of Washington, University of Colorado and Seattle Children's Research Institute.